These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 6791675)

  • 1. In vitro sensitivity of human ovarian tumours to chemotherapeutic agents.
    Wilson AP; Neal FE
    Br J Cancer; 1981 Aug; 44(2):189-200. PubMed ID: 6791675
    [TBL] [Abstract][Full Text] [Related]  

  • 2. cis-platinum and ovarian carcinoma. In vitro chemosensitivity of cultured tumour cells from patients receiving high dose cis-platinum as first line treatment.
    Wilson AP; Ford CH; Newman CE; Howell A
    Br J Cancer; 1987 Dec; 56(6):763-73. PubMed ID: 3435704
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fresh explant culture of human tumours in vitro and the assessment of sensitivity to cytotoxic chemotherapy.
    Berry RJ; Laing AH; Wells J
    Br J Cancer; 1975 Feb; 31(2):218-27. PubMed ID: 809049
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro sensitivity of human ovarian tumors to chemotherapeutic agents with adjuvant danazol.
    Hunter G; Ashton KJ; Merry B
    Obstet Gynecol; 1987 Feb; 69(2):233-6. PubMed ID: 3808508
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibitory effects of combinations of HER-2/neu antibody and chemotherapeutic agents used for treatment of human breast cancers.
    Pegram M; Hsu S; Lewis G; Pietras R; Beryt M; Sliwkowski M; Coombs D; Baly D; Kabbinavar F; Slamon D
    Oncogene; 1999 Apr; 18(13):2241-51. PubMed ID: 10327070
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical correlates of in vitro drug sensitivities of ovarian cancer cells.
    Morasca L; Erba E; Vaghi M; Ghelardoni C; Mangioni C; Sessa C; Landoni F; Garattini S
    Br J Cancer; 1983 Jul; 48(1):61-8. PubMed ID: 6409137
    [TBL] [Abstract][Full Text] [Related]  

  • 7. S100P contributes to chemosensitivity of human ovarian cancer cell line OVCAR3.
    He Z; Gao J; Wang Q; Liu M; Li Y; Li X; Tang H; Zheng J
    Oncol Rep; 2008 Aug; 20(2):325-32. PubMed ID: 18636193
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetic approach to in vitro testing of ovarian cancer cell sensitivity.
    Morasca L; Balconi G; Erba E; D'Incalci M; Ottolenghi L; Salmona A; Garattini S
    Oncology; 1980; 37(3):169-73. PubMed ID: 7360488
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combination chemotherapy of advanced ovarian carcinoma with the antimetabolite, methotrexate, and the alkylating agent, thioTEPA.
    GREENSPAN EM; FIEBER M
    J Mt Sinai Hosp N Y; 1962; 29():48-62. PubMed ID: 13901566
    [No Abstract]   [Full Text] [Related]  

  • 10. [On the problem of praetherapeutic sensitivity testing of human tumours based on incorporation studies of nucleic acid precursors in vitro (author's transl)].
    Seeber S; Schmidt CG
    Klin Wochenschr; 1977 Dec; 55(23):1127-36. PubMed ID: 340776
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [A new in vitro chemosensitivity test. Individualized chemotherapy against ovarian cancer and its clinical effect].
    Takamizawa H; Sekiya S; Iwasawa H; Ishige H; Tokita H; Tanaka N
    Gan To Kagaku Ryoho; 1985 Dec; 12(12):2293-7. PubMed ID: 2416274
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of single, short-term exposures of human retinal pigment epithelial cells to thiotepa or 5-fluorouracil: implications for the treatment of proliferative vitreoretinopathy.
    Kon CH; Occleston NL; Foss A; Sheridan C; Aylward GW; Khaw PT
    Br J Ophthalmol; 1998 May; 82(5):554-60. PubMed ID: 9713065
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [-Chemosensitivity testing in gynecologic oncology. Experiences with an ATP bioluminescence assay-].
    Kurbacher CM; Mallmann P; Kurbacher JA; Hübner H; Krebs D
    Geburtshilfe Frauenheilkd; 1996 Feb; 56(2):70-8. PubMed ID: 8647362
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Experimental correlations of in vitro drug sensitivity with in vivo responses to ThioTEPA in a panel of murine colon tumours.
    Phillips RM; Bibby MC; Double JA
    Cancer Chemother Pharmacol; 1988; 21(2):168-72. PubMed ID: 3127072
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ovarian carcinoma cells in culture: assessment of drug sensitivity by clonogenic assay.
    Simmonds AP; McDonald EC
    Br J Cancer; 1984 Sep; 50(3):317-26. PubMed ID: 6540594
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytotoxic drugs and the human adrenal cortex: a cell culture study.
    Morgan MW; O'Hare MJ
    Cancer; 1979 Mar; 43(3):969-79. PubMed ID: 218719
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro activity of alkylating agents on human tumors as measured by a short-term antimetabolic assay.
    Zaffaroni N; Silvestrini R; Sanfilippo O; Daidone MG; Gasparini G
    Tumori; 1985 Dec; 71(6):555-61. PubMed ID: 4082288
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incubation of surviving sections of ovarian tumours as a method of testing their sensitivity to cytostatics.
    Merkulov M; Leskova S
    Neoplasma; 1972; 19(4):283-91. PubMed ID: 4626589
    [No Abstract]   [Full Text] [Related]  

  • 19. Use of nude mouse xenografts as preclinical drug screens: in vivo activity of established chemotherapeutic agents against melanoma and ovarian carcinoma xenografts.
    Taetle R; Rosen F; Abramson I; Venditti J; Howell S
    Cancer Treat Rep; 1987 Mar; 71(3):297-304. PubMed ID: 3815395
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Primary treatment of advanced ovarian adenocarcinoma, stages III and IV.
    Piver S; Barlow JJ; Chung WS; Lee FT; Vongtama V
    Natl Cancer Inst Monogr; 1975 Oct; 42():177-82. PubMed ID: 825780
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.